Effects of zearalenone on mRNA expression and activity of cytochrome P450 1A1 and 1B1 in MCF-7 cells

Ecotoxicology and Environmental Safety

Volumn 58, Issue 2, 2004, Pages 187-193

  Yu, Zengli ^a   Hu, Dongsheng ^a   Li, Yin ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b Department of Thoracic Surgery   (China)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin (TCDD); CYP1A1; CYP1B1; Human breast cancer cell line MCF 7; Zearalenone

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 HYDROXYTAMOXIFEN; ANTIESTROGEN; COMPLEMENTARY DNA; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTRADIOL; ETHOXYRESORUFIN DEETHYLASE; ZEARALANONE;

CANCER; CARCINOGEN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; INSECT CELL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ARYL HYDROCARBON HYDROXYLASES; BIOLOGICAL ASSAY; BREAST NEOPLASMS; CYTOCHROME P-450 CYP1A1; ENZYME ACTIVATION; ENZYME INDUCTION; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; ESTROGENS, NON-STEROIDAL; FEMALE; GENE EXPRESSION; HUMANS; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TUMOR CELLS, CULTURED; ZEARALENONE;

INSECTA; MAMMALIA; MINK CELL FOCUS-FORMING VIRUS; UNIDENTIFIED BACULOVIRUS; ZEA;

EID: 2442423985     PISSN: 01476513     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecoenv.2004.03.001     Document Type: Article

References (45)

1. Borchardt R.T. Catechol O-methyltransferase. Methods Enzymol. 77:1981;267-272
2. Bucheli T.D., Fent K. Induction of cytochrome P450 as a biomarker of environmental contamination in aquatic ecosystems. Crit. Rev. Environ. Sci. Technol. 25:1995;201-268
3. Burke M.D., Mayer R.T. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chem. Biol. Interact. 45(2):1983;243-258
4. Cao K., Stack D.E., Ramanathan R., Gross M.L., Rogan E.G., Cavalieri E.L. Synthesis and structure elucidation of estrogen quinines conjugated with cysteine, N-acetylcysteine, and glutathione. Chem. Res. Toxicol. 11:1998;909-916
5. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cemy R.L., Rogan E.G. Molecular origin of cancer. catechol estrogen-3, 4-quinones as endogenous tumor initiators Proc. Natl. Acad. Sci. USA. 94:1997;10937-10942
6. Cavalieri E., Frenkel K., Liehr J.G., Rogan E., Roy D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 27:2000;75-93
7. Coumoul X., Diry M., Robillot C., Barouki R. Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7. Cancer Res. 61(10):2001;3942-3948
8. Crespi C.L., Penman B.W., Steimel D.T., Smith T., Yang C.S., Sutter T.R. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA. substrate specificity with model substrates and promutagens Mutagenesis. 12:1997;83-89
9. Davila D.R., Romero D.L., Burchiel S.W. Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by alpha-naphthoflavone. Toxicol. Appl. Pharmacol. 139:1996;333-341
10. Davis D.L., Bradlow H.L., Wolff M., Woodruff T., Hoel D.G., Anton-Culver H. Medical hypothesis. xenoestrogens as preventable causes of breast cancer Environ. Health Perspect. 101:1993;372-377
11. Dawling S., Roodi N., Mernaugh R.L., Wang X., Parl F.F. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens. comparison of wild-type and variant COMT isoforms Cancer Res. 61:2001;6716-6722
12. D'Mello J.P.F., Placinta C.M., MacDonald A.M.C. Fusarium mycotoxins. a review of global animal health, welfare and reproductivity Anim. Feed Sci. Technol. 80:1999;183-205
13. Etienne M., Dourmand J.Y. Effects of Zearalenone or glucosinolates in the diet on reproduction in sows. a review Livest. Prod. Sci. 40:1994;99-113
14. Forman D., Moller H. Testicular cancer. Cancer Surv. 19-20:1994;323-341
15. Fotsis T., Zhang Y., Pepper M.S., Adlercreutz H., Montesano R., Nawroth P.P., Schweigerer L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature. 368:1994;237-239
16. Fuqua S.A., Fitzgerald S.D., McGuire W.L. A simple polymerase chain reaction method for detection and cloning of low-abundance transcripts. Biotechniques. 9(2):1990;206-211
17. Heimler I., Rawlins R.G., Owen H., Hutz R.J. Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of human luteinized granulosa cells. Endocrinology. 139:1998;4373-4379
18. Hutz R.J. Reproductive endocrine disruption by environmental xenobiotics that modulate the estrogen signaling pathway. Reprod. Dev. 45:1999;1-12
19. Ito Y., Ohtsubo K.I. Effects of administration of Zearalenone on the reproductive physiology of female mice. J. Vet. Sci. 56:1994;1155-1159
20. Kinoshita T., Imamura J., Nagai H., Shimotohno K. Quantification of gene expression over a wide range by polymerase chain reaction. Anal. Biochem. 206:1992;231-235
21. Liehr J.G. Dual role of oestrogens as hormones and pro-carcinogens. tumour initiation by metabolic activation of oestrogens Eur. J. Cancer Prev. 6:1997;3-10
22. Liehr J.G., Ricci M.J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA. 93:1996;3294-3296
23. Makela S., Davis V.L., Tally W.C., Korkman J., Salo L., Vihko R., Santti R., Korach K.S. Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ. Health Perspect. 102(6-7):1994;572-578
24. Mannisto P.T., Kaakkola S. Catechol-O-methyltransferase (COMT). biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors Pharmacol. Rev. 51:1999;593-628
25. Muto T., Wakui S., Imano N., Nakaaki K., Takahashi H., Hano H., Furusato M., Masaoka T. Mammary gland differentiation in female rats after prenatal exposure to 3, 3_, 4, 4_, 5-pentachlorobiphenyl. Toxicology. 177:2002;197-205
26. Newbold R.R., Bullock B.C., McLachlan J.A. Adenocarcinoma of the rete testis. Diethylstilbestrol-induced lesions of the mouse rete testis. Am. J. Pathol. 125:1986;625-628
27. Placinta C.M., D'Mello J.P.F., Mac Donald A.M.C. A review of worldwide contamination of cereal grains and animal feed with Fusarium mycotoxins. Anim. Feed Sci. Technol. 78:1999;21-37
28. Safe S.H. Modulation of gene expression and endocrine response pathways by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther. 67(2):1995;247-281
29. Safe S.H. Interactions between hormones and chemicals in breast cancer. Annu. Rev. Pharmacol. Toxicol. 38:1998;121-158
30. Saintot M., Malaveille C., Hautefeuille A., Gerber M. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-O-methyltransferase and tobacco exposure in breast cancer risk. Int. J. Cancer. 107:2003;652-657
31. Sarkar S., Jana N.R., Yonemoto C., Tohyama C., Sone H. Estrogen enhances induction of cytochrome P-4501A1 by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in liver of female Long-Evans rats. Int. J. Oncol. 16:2000;141-147
32. Shimada T., Gillam E.M., Sutter T.R., Strickland P.T., Guengerich F.P, Yamazaki H. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab. Dispos. 25:1997;617-622
33. Son D.S., Ushinohama K., Gao X., Taylor C.C., Roby K.F., Rozman K.K., Terranova P.F. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) blocks ovulation by a direct action on the ovary without alteration of ovarian steroidogenesis. lack of a direct effect on ovarian granulosa and thecal-interstitial cell steroidogenesis in vitro Reprod. Toxicol. 13:1999;521-530
34. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Serrano F.O. The E-SCREEN assay as a tool to identify estrogens. an update on estrogenic environmental pollutants Environ. Health Perspect. 103:1995;113-122
35. Spink B.C., Fasco M.C., Gierthy J.F., Spink D.C. 12- OTetradecanoylphorbol-13-Acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells. J. Cell. Biochem. 70:1998;289-296
36. Spink D.C., Spink B.C., Cao J.Q., DePasquale J.A., Pentecost B.T., Fasco M.J., Li Y., Sutter T.R. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis. 19:1998;291-298
37. Spink B.C., Hussain M.M., Katz B.H., Eisele L., Spink D.C. Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. Biochem. Pharmacol. 66:2003;2313-2321
38. Spink D.C., Katz B.H., Hussain M.M., Pentecost B.T., Cao Z., Spink B.C. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis. 24:2003;1941-1950
39. Sugimura K., Ohno T., Kusuyama T., Azuma I. High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro. Melanoma Res. 2(3):1992;191-196
40. van Duursen M.B., Sanderson J.T., van der Bruggen M., van der Linden J., van den Berg M. Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines. Toxicol. Appl. Pharmacol. 190:2003;241-250
41. Warner M., Eskenazi B., Mocarelli P., Gerthoux P.M., Samuels S., Needham L., Patterson D., Brambilla P. Serum dioxin concentrations and breast cancer risk in the Seveso women's health study. Environ. Health Perspect. 110:2002;625-628
42. Weisz J., Clawson G.A., Crevelingen C.R. Biogenesis and inactivation of catecholestrogens. Adv. Pharmacol. 42:1998;828-833
43. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 27:2000;67-73
44. Yue W., Santen R.J., Wang J.P., Li Y., Verderame M.F., Bocchinfuso W.P., Korach K.S., Devanesan P., Todorovic R., Rogan E.G., Cavalieri E.L. Genotoxic metabolites of estradiol in breast. potential mechanism of estradiol induced carcinogenesis J. Steroid Biochem. Mol. Biol. 86:2003;477-486
45. Zhu B.T., Conney A.H. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 58:1998;2269-2277